300
Participants
Start Date
March 31, 2010
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
rhEGF
rhEGF 50 μg/ml, spray type, twice a day
Placebo
Placebo, Spray type, Twice a day
Asan medical center, Seoul
Seoul National Colleage & Hospital, Seoul
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
INDUSTRY